Geraldine Pignot

Marseille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 195 publications

De-escalation of Treatment in Metastatic Renal Cell Carcinoma: Why? How? Who? When?

De-escalation of Treatment in Metastatic Renal Cell Carcinoma: Why? How? Who? When?

Journal: Clinical genitourinary cancer

Published: March 11, 2026

Management of Lymph Node-Positive Renal Cell Carcinoma: Updated Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel.

Management of Lymph Node-Positive Renal Cell Carcinoma: Updated Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel.

Journal: European urology

Published: February 13, 2026

Clinical and Pathological Features Associated with Chromophobe Renal Cell Carcinoma Recurrence: Analysis from a Nationwide Cohort.

Clinical and Pathological Features Associated with Chromophobe Renal Cell Carcinoma Recurrence: Analysis from a Nationwide Cohort.

Journal: European urology open science

Published: October 31, 2025

ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC).

ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC).

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 05, 2025

Chemotherapy-induced anemia as a prognostic factor for overall survival in patients with bladder cancer treated with neoadjuvant cisplatin-based chemotherapy and cystectomy.

Chemotherapy-induced anemia as a prognostic factor for overall survival in patients with bladder cancer treated with neoadjuvant cisplatin-based chemotherapy and cystectomy.

Journal: World journal of urology

Published: September 05, 2025

Chemotherapy use in triplet approach for metastatic hormone-sensitive prostate cancer: French practice survey and expert opinion.

Chemotherapy use in triplet approach for metastatic hormone-sensitive prostate cancer: French practice survey and expert opinion.

Journal: The French journal of urology

Published: July 07, 2025

Primary urethral cancer: Treatment patterns, responses and survival in localized, advanced and metastatic patients.

Primary urethral cancer: Treatment patterns, responses and survival in localized, advanced and metastatic patients.

Journal: BJUI compass

Published: June 29, 2025

A multidisciplinary approach to managing non-metastatic castration resistant prostate cancer: Insights from a national practice survey.

A multidisciplinary approach to managing non-metastatic castration resistant prostate cancer: Insights from a national practice survey.

Journal: The French journal of urology

Published: June 25, 2025

Adjuvant radiotherapy in patients with pathological high-risk bladder cancer: Acute toxicity results from a randomized multicentre phase II trial (Bladder-ART/GETUG-AFU30).

Adjuvant radiotherapy in patients with pathological high-risk bladder cancer: Acute toxicity results from a randomized multicentre phase II trial (Bladder-ART/GETUG-AFU30).

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: May 17, 2025

Erdafitinib in Patients with High- and Intermediate-risk Non-muscle-invasive Bladder Cancer: Final Analysis of THOR-2 Study.

Erdafitinib in Patients with High- and Intermediate-risk Non-muscle-invasive Bladder Cancer: Final Analysis of THOR-2 Study.

Journal: European urology

Published: May 16, 2025

Can bladder MRI avoid systematic second TURBT for patients with high-risk NMIBC?

Can bladder MRI avoid systematic second TURBT for patients with high-risk NMIBC?

Journal: World journal of urology

Published: April 12, 2025

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update.

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update.

Journal: European urology

Published: February 17, 2025

Showing 1-12 of 195

Last Updated: 09/26/2026